195 related articles for article (PubMed ID: 37612452)
21. Identification of key transcription factors in endometrial cancer by systems bioinformatics analysis.
Song Y; Chen QT; He QQ
J Cell Biochem; 2019 Sep; 120(9):15443-15454. PubMed ID: 31037767
[TBL] [Abstract][Full Text] [Related]
22. Aneuploidy related transcriptional changes in endometrial cancer link low expression of chromosome 15q genes to poor survival.
Mauland KK; Wik E; Hoivik EA; Kusonmano K; Halle MK; Berg A; Haugland HK; Øyan AM; Kalland KH; Stefansson IM; Akslen LA; Krakstad C; Trovik J; Werner HM; Salvesen HB
Oncotarget; 2017 Feb; 8(6):9696-9707. PubMed ID: 28039471
[TBL] [Abstract][Full Text] [Related]
23. Hsa-microRNA-181a is a regulator of a number of cancer genes and a biomarker for endometrial carcinoma in patients: a bioinformatic and clinical study and the therapeutic implication.
He S; Zeng S; Zhou ZW; He ZX; Zhou SF
Drug Des Devel Ther; 2015; 9():1103-75. PubMed ID: 25733820
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of an autophagy-related long-noncoding-RNA signature for endometrial cancer.
Wang X; Dai C; Ye M; Wang J; Lin W; Li R
Aging (Albany NY); 2021 Feb; 13(4):5104-5119. PubMed ID: 33534780
[TBL] [Abstract][Full Text] [Related]
25. Metabolomic and Lipidomic Profiling Identifies The Role of the RNA Editing Pathway in Endometrial Carcinogenesis.
Altadill T; Dowdy TM; Gill K; Reques A; Menon SS; Moiola CP; Lopez-Gil C; Coll E; Matias-Guiu X; Cabrera S; Garcia A; Reventos J; Byers SW; Gil-Moreno A; Cheema AK; Colas E
Sci Rep; 2017 Aug; 7(1):8803. PubMed ID: 28821813
[TBL] [Abstract][Full Text] [Related]
26. Identifying and optimizing human endometrial gene expression signatures for endometrial dating.
Diaz-Gimeno P; Sebastian-Leon P; Sanchez-Reyes JM; Spath K; Aleman A; Vidal C; Devesa-Peiro A; Labarta E; Sánchez-Ribas I; Ferrando M; Kohls G; García-Velasco JA; Seli E; Wells D; Pellicer A
Hum Reprod; 2022 Jan; 37(2):284-296. PubMed ID: 34875061
[TBL] [Abstract][Full Text] [Related]
27. Multi-tissue transcriptome-wide association study identifies eight candidate genes and tissue-specific gene expression underlying endometrial cancer susceptibility.
Kho PF; Wang X; Cuéllar-Partida G; Dörk T; Goode EL; Lambrechts D; Scott RJ; Spurdle AB; O'Mara TA; Glubb DM
Commun Biol; 2021 Oct; 4(1):1211. PubMed ID: 34675350
[TBL] [Abstract][Full Text] [Related]
28. Transcriptomic analysis of hormone-sensitive patient-derived endometrial cancer spheroid culture defines Efp as a proliferation modulator.
Yang C; Ikeda K; Horie-Inoue K; Sato W; Hasegawa K; Takeda S; Itakura A; Inoue S
Biochem Biophys Res Commun; 2021 Apr; 548():204-210. PubMed ID: 33647797
[TBL] [Abstract][Full Text] [Related]
29. TTK, CDC25A, and ESPL1 as Prognostic Biomarkers for Endometrial Cancer.
Yang Q; Yu B; Sun J
Biomed Res Int; 2020; 2020():4625123. PubMed ID: 33282948
[TBL] [Abstract][Full Text] [Related]
30. Identification of six candidate genes for endometrial carcinoma by bioinformatics analysis.
Zhu Y; Shi L; Chen P; Zhang Y; Zhu T
World J Surg Oncol; 2020 Jul; 18(1):161. PubMed ID: 32641130
[TBL] [Abstract][Full Text] [Related]
31. Multiomics profiling of the expression and prognosis of MCMs in endometrial carcinoma.
Lan H; Yuan J; Chen X; Liu C; Guo X; Wang X; Song J; Cao K; Xiao S
Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34859821
[TBL] [Abstract][Full Text] [Related]
32. An EMT-related genes signature as a prognostic biomarker for patients with endometrial cancer.
Yu Y; Zhang Y; Li Z; Dong Y; Huang H; Yang B; Zhao E; Chen Y; Yang L; Lu J; Qiu F
BMC Cancer; 2023 Sep; 23(1):879. PubMed ID: 37723477
[TBL] [Abstract][Full Text] [Related]
33. A novel five-gene metabolism-related risk signature for predicting prognosis and immune infiltration in endometrial cancer: A TCGA data mining.
Huang H; Cai X; Lin J; Wu Q; Zhang K; Lin Y; Liu B; Lin J
Comput Biol Med; 2023 Mar; 155():106632. PubMed ID: 36805217
[TBL] [Abstract][Full Text] [Related]
34. Protein-based prognostic signature for predicting the survival and immunotherapeutic efficiency of endometrial carcinoma.
Lai J; Xu T; Yang H
BMC Cancer; 2022 Mar; 22(1):325. PubMed ID: 35337291
[TBL] [Abstract][Full Text] [Related]
35. TCGA dataset screening for genes implicated in endometrial cancer using RNA-seq profiling.
Fu X; Cheng S; Wang W; Shi O; Gao F; Li Y; Wang Q
Cancer Genet; 2021 Jun; 254-255():40-47. PubMed ID: 33588182
[TBL] [Abstract][Full Text] [Related]
36. Identification of molecular markers and signaling pathway in endometrial cancer in Hong Kong Chinese women by genome-wide gene expression profiling.
Wong YF; Cheung TH; Lo KW; Yim SF; Siu NS; Chan SC; Ho TW; Wong KW; Yu MY; Wang VW; Li C; Gardner GJ; Bonome T; Johnson WB; Smith DI; Chung TK; Birrer MJ
Oncogene; 2007 Mar; 26(13):1971-82. PubMed ID: 17043662
[TBL] [Abstract][Full Text] [Related]
37. An miRNA signature associated with tumor mutation burden in endometrial cancer.
Zhou H; Chen L; Qin M; Lei Y; Li T; Li H; Cheng X
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33141168
[TBL] [Abstract][Full Text] [Related]
38. Analysis and experimental validation of fatty acid metabolism-related genes prostacyclin synthase (PTGIS) in endometrial cancer.
Wang B; Ge S; Wang Z; Wang W; Wang Y; Leng H; Ma X
Aging (Albany NY); 2023 Oct; 15(19):10322-10346. PubMed ID: 37796199
[TBL] [Abstract][Full Text] [Related]
39. Identification of a novel subgroup of endometrial cancer patients with loss of thyroid hormone receptor beta expression and improved survival.
Piqué DG; Greally JM; Mar JC
BMC Cancer; 2020 Sep; 20(1):857. PubMed ID: 32894083
[TBL] [Abstract][Full Text] [Related]
40. An immune-related pseudogene signature to improve prognosis prediction of endometrial carcinoma patients.
Tang S; Zhuge Y
Biomed Eng Online; 2021 Jun; 20(1):64. PubMed ID: 34193185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
